Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy.
Bastola S, Pavlyukov MS, Yamashita D, Ghosh S, Cho H, Kagaya N, Zhang Z, Minata M, Lee Y, Sadahiro H, Yamaguchi S, Komarova S, Yang E, Markert J, Nabors LB, Bhat K, Lee J, Chen Q, Crossman DK, Shin-Ya K, Nam DH, Nakano I. Bastola S, et al. Among authors: pavlyukov ms. Nat Commun. 2020 Sep 16;11(1):4660. doi: 10.1038/s41467-020-18189-y. Nat Commun. 2020. PMID: 32938908 Free PMC article.
Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complex.
Guvenc H, Pavlyukov MS, Joshi K, Kurt H, Banasavadi-Siddegowda YK, Mao P, Hong C, Yamada R, Kwon CH, Bhasin D, Chettiar S, Kitange G, Park IH, Sarkaria JN, Li C, Shakhparonov MI, Nakano I. Guvenc H, et al. Among authors: pavlyukov ms. Clin Cancer Res. 2013 Feb 1;19(3):631-42. doi: 10.1158/1078-0432.CCR-12-0647. Epub 2012 Dec 18. Clin Cancer Res. 2013. PMID: 23251006 Free PMC article.
FOXD1-ALDH1A3 Signaling Is a Determinant for the Self-Renewal and Tumorigenicity of Mesenchymal Glioma Stem Cells.
Cheng P, Wang J, Waghmare I, Sartini S, Coviello V, Zhang Z, Kim SH, Mohyeldin A, Pavlyukov MS, Minata M, Valentim CL, Chhipa RR, Bhat KP, Dasgupta B, La Motta C, Kango-Singh M, Nakano I. Cheng P, et al. Among authors: pavlyukov ms. Cancer Res. 2016 Dec 15;76(24):7219-7230. doi: 10.1158/0008-5472.CAN-15-2860. Epub 2016 Aug 28. Cancer Res. 2016. PMID: 27569208 Free PMC article.
Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.
Wang J, Cheng P, Pavlyukov MS, Yu H, Zhang Z, Kim SH, Minata M, Mohyeldin A, Xie W, Chen D, Goidts V, Frett B, Hu W, Li H, Shin YJ, Lee Y, Nam DH, Kornblum HI, Wang M, Nakano I. Wang J, et al. Among authors: pavlyukov ms. J Clin Invest. 2017 Aug 1;127(8):3075-3089. doi: 10.1172/JCI89092. Epub 2017 Jul 24. J Clin Invest. 2017. Retraction in: J Clin Invest. 2020 Nov 2;130(11):6187. doi: 10.1172/JCI144618. PMID: 28737508 Free PMC article. Retracted.
Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors.
Pavlyukov MS, Yu H, Bastola S, Minata M, Shender VO, Lee Y, Zhang S, Wang J, Komarova S, Wang J, Yamaguchi S, Alsheikh HA, Shi J, Chen D, Mohyeldin A, Kim SH, Shin YJ, Anufrieva K, Evtushenko EG, Antipova NV, Arapidi GP, Govorun V, Pestov NB, Shakhparonov MI, Lee LJ, Nam DH, Nakano I. Pavlyukov MS, et al. Cancer Cell. 2018 Jul 9;34(1):119-135.e10. doi: 10.1016/j.ccell.2018.05.012. Epub 2018 Jun 21. Cancer Cell. 2018. PMID: 29937354 Free PMC article.
Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation.
Minata M, Audia A, Shi J, Lu S, Bernstock J, Pavlyukov MS, Das A, Kim SH, Shin YJ, Lee Y, Koo H, Snigdha K, Waghmare I, Guo X, Mohyeldin A, Gallego-Perez D, Wang J, Chen D, Cheng P, Mukheef F, Contreras M, Reyes JF, Vaillant B, Sulman EP, Cheng SY, Markert JM, Tannous BA, Lu X, Kango-Singh M, Lee LJ, Nam DH, Nakano I, Bhat KP. Minata M, et al. Among authors: pavlyukov ms. Cell Rep. 2019 Feb 12;26(7):1893-1905.e7. doi: 10.1016/j.celrep.2019.01.076. Cell Rep. 2019. PMID: 30759398 Free PMC article.
Investigation of Inter- and Intratumoral Heterogeneity of Glioblastoma Using TOF-SIMS.
Gularyan SK, Gulin AA, Anufrieva KS, Shender VO, Shakhparonov MI, Bastola S, Antipova NV, Kovalenko TF, Rubtsov YP, Latyshev YA, Potapov AA, Pavlyukov MS. Gularyan SK, et al. Among authors: pavlyukov ms. Mol Cell Proteomics. 2020 Jun;19(6):960-970. doi: 10.1074/mcp.RA120.001986. Epub 2020 Apr 6. Mol Cell Proteomics. 2020. PMID: 32265293 Free PMC article.
Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.
Wang J, Cheng P, Pavlyukov MS, Yu H, Zhang Z, Kim SH, Minata M, Mohyeldin A, Xie W, Chen D, Goidts V, Frett B, Hu W, Li H, Shin YJ, Lee Y, Nam DH, Kornblum HI, Wang M, Nakano I. Wang J, et al. Among authors: pavlyukov ms. J Clin Invest. 2020 Sep 1;130(9):5027. doi: 10.1172/JCI142404. J Clin Invest. 2020. PMID: 32870163 Free PMC article. No abstract available.
Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.
Wang J, Cheng P, Pavlyukov MS, Yu H, Zhang Z, Kim SH, Minata M, Mohyeldin A, Xie W, Chen D, Goidts V, Frett B, Hu W, Li H, Shin YJ, Lee Y, Nam DH, Kornblum HI, Wang M, Nakano I. Wang J, et al. Among authors: pavlyukov ms. J Clin Invest. 2020 Nov 2;130(11):6187. doi: 10.1172/JCI144618. J Clin Invest. 2020. PMID: 33044225 Free PMC article. No abstract available.
34 results